Purpose | Announcement Date | Right Issue Date | Record Date | Rights Ratio | Premium | Remark |
---|---|---|---|---|---|---|
Rights | 3 Jan 2024 | 9 Jan 2024 | 9 Jan 2024 | 1:1 | 0.75 | 1:1 Rights Issue of Equity Shares |
1:1 Rights Issue of Equity Shares Trading Members of the Exchange are hereby informed that GENPHARMASEC LTD has fixed Record date for the purpose of Rights Issue of Equity Shares of the Company. The transactions in the Equity Shares of the Company should be done on Ex-Rights basis with effect from the under mentioned date :- DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE GENPHARMASEC LTD (531592) RECORD DATE 09.01.2024 PURPOSE Issue of 1 (One) Equity Shares of Re.1/- each for cash at a premium of Rs.0.75 per Equity Share on Rights Basis for every 1 (One) Equity Share held.* Ex-Right basis from Date & Sett. No. 09/01/2024 DR-692/2023-2024 *As per the Terms of the Payment : - Full amount of the Issue Price of Rs.1.75 per Rights Equity Share shall be payable at the time of Application Trading Members of the Exchange are requested to take note of it. (As Per BSE Notice Dated on 04.01.2024) |
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.